Zobrazeno 1 - 10
of 134
pro vyhledávání: '"Barney J Stern"'
Autor:
John W Cole, O Colin Stine, Xinyue Liu, Abhishek Pratap, Yuching Cheng, Luke J Tallon, Lisa K Sadzewicz, Nicole Dueker, Marcella A Wozniak, Barney J Stern, James F Meschia, Braxton D Mitchell, Steven J Kittner, Jeffrey R O'Connell
Publikováno v:
PLoS ONE, Vol 7, Iss 4, p e35591 (2012)
The genetic architecture of ischemic stroke is complex and is likely to include rare or low frequency variants with high penetrance and large effect sizes. Such variants are likely to provide important insights into disease pathogenesis compared to c
Externí odkaz:
https://doaj.org/article/4a6c4e5b22034bc4be3ca390a8735b34
Publikováno v:
Seminars in Neurology. 41:673-685
Facial palsy is a common neurologic concern and is the most common cranial neuropathy. The facial nerve contains motor, parasympathetic, and special sensory functions. The most common form of facial palsy is idiopathic (Bell's palsy). A classic prese
Autor:
Sneha Mantri, Ericka P Greene, Richard J. Bonnie, Matthew Kirschen, Daniel G. Larriviere, Law Ethics, Salvador Cruz-Flores, Michael Rubin, Benjamin Tolchin, Leon G. Epstein, Judy Illes, Winston Chiong, Lynne Taylor, Barney J. Stern, Katharina M. Busl
Publikováno v:
Neurology. 98:154-159
Publikováno v:
Seminars in Respiratory and Critical Care Medicine. 41(05):641-651
Neurosarcoidosis (NS) is an often severe, destructive manifestation with a likely under-reported prevalence of 5 to 15% of sarcoidosis cases, and in its active phase demands timely treatment intervention. Clinical signs and symptoms of NS are variabl
Autor:
Jingyuan Chou, Ann N. Poncelet, Fei Wang, Barney J. Stern, Katherine C. Nickels, Joshua Weaver, Susannah Cornes, Daniel Weber, Joseph Safdieh, Harini Sarva
Publikováno v:
Neurology. 93:30-34
In the current medical climate, medical education is at risk of being de-emphasized, leading to less financial support and compensation for faculty. A rise in compensation plans that reward clinical or research productivity fails to incentivize and t
Autor:
Paula, Barreras, Barney J, Stern
Publikováno v:
Journal of Neuroimmunology. 368:577871
Neurosarcoidosis affects 5-26% of patients with systemic sarcoidosis and can be the first or only manifestation of the disease. Neurosarcoidosis can affect any part of the nervous system with heterogeneous clinical manifestations and imaging appearan
Autor:
David B. Clifford, Siddharama Pawate, Jeffrey M. Gelfand, Allan Krumholz, David R. Moller, Jinny Tavee, Marjolein Drent, Allen J. Aksamit, Walter Royal, Marc A. Judson, Robert P. Baughman, Barney J. Stern, Joseph R. Berger, Carlos A. Pardo
Publikováno v:
JAMA Neurology. 75(12):1546-1553
Importance The Neurosarcoidosis Consortium Consensus Group, an expert panel of physicians experienced in the management of patients with sarcoidosis and neurosarcoidosis, engaged in an iterative process to define neurosarcoidosis and develop a practi
Autor:
Samantha Harris, Brittany L. Adler, Clifton O. Bingham, Ana Maria Orbai, Ahmet Hoke, Homa Timlin, Lisa Christopher-Stine, Allan C. Gelber, Berna Aravidis, Jemima Albayda, Carlos A. Pardo, Brindusa Truta, Barney J. Stern, Pavan Bhargava, Edward K. Kasper, Kathryn C. Fitzgerald, Michelle Petri, Edward S. Chen, Christopher A. Mecoli, Mark Lazarev, Nisha A. Gilotra, Ami A. Shah, Ellen M. Mowry, Shiv Saidha, Scott D. Newsome, Julie J. Paik, Thomas E. Lloyd, Morgan Douglas, Alan N. Baer, Vinay Chaudhry, Eleni Tiniakou, Michelle Sharp, Elias S. Sotirchos, Arun Venkatesan
Publikováno v:
medRxiv
Background People with autoimmune or inflammatory conditions taking immunomodulatory/suppressive medications may have higher risk of novel coronavirus disease 2019 (COVID-19). Chronic disease care has also changed for many patients, with uncertain do
Autor:
Carlos A. Pardo, Samantha Harris, Brindusa Truta, Ami A. Shah, Ellen M. Mowry, Shiv Saidha, Kathryn C. Fitzgerald, Edward S. Chen, Julie J. Paik, Brittany L. Adler, Ana Maria Orbai, Barney J. Stern, Lisa Christopher-Stine, Allan C. Gelber, Homa Timlin, Jemima Albayda, Berna Aravidis, Arun Venkatesan, Elias S. Sotirchos, Eleni Tiniakou, Michelle Sharp, Thomas E. Lloyd, Scott D. Newsome, Morgan Douglas, Ahmet Hoke, Christopher A. Mecoli, Edward K. Kasper, Pavan Bhargava, Michelle Petri, Nisha A. Gilotra, Clifton O. Bingham, Vinay Chaudhry, Alan N. Baer, Mark Lazarev
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
BackgroundPeople with autoimmune or inflammatory conditions who take immunomodulatory/suppressive medications may have a higher risk of novel coronavirus disease 2019 (COVID-19). Chronic disease care has also changed for many patients, with uncertain
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::faa627ff7b01ef785b6875e80e10c8ed
https://doi.org/10.1101/2021.02.03.21251069
https://doi.org/10.1101/2021.02.03.21251069